GENETIC ANALYSIS NK -60 (8V8) — Cash Flow Reinvestment Rate
GENETIC ANALYSIS NK -60 (8V8) has a Cash Flow Reinvestment Rate of 0.17x as of December 2025, reinvesting €1.36 Million (capex €1.36 Million ) from operating cash flow of €8.04 Million. See free cash flow generation of GENETIC ANALYSIS NK -60 to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GENETIC ANALYSIS NK -60 Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for GENETIC ANALYSIS NK -60 across 1 annual periods. For the full cash flow conversion analysis, see GENETIC ANALYSIS NK -60 (8V8) cash flow conversion.
Annual Cash Flow Reinvestment Rate for GENETIC ANALYSIS NK -60 (2025–2025)
Year-by-year capital reinvestment analysis for GENETIC ANALYSIS NK -60. See financial flexibility index of GENETIC ANALYSIS NK -60 to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.31x | €5.54 Million | €2.40 Million | €5.54 Million | — |